Rongfeng Qu
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 8
- Reproductive Medicine top 10%
-
- Circular RNAs in diseases 8
- CRISPR and Genetic Engineering 1
-
- Virus-based gene therapy research 1
-
- Lymphoma Diagnosis and Treatment 2
-
- Conducting polymers and applications 1
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 1
- Co-authors
- Yarong LiWenxian ZengYing HeXiue TianGuang ShiYaqing ZhangYi ZhengRui Liu
- Partner nations
- China
In The Last Decade
Rongfeng Qu
13 papers receiving 275 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 129
- Reproductive Medicine 58
- Molecular Biology 174
- Public Health, Environmental and Occupational Health 46
- Genetics 43
Countries citing papers authored by Rongfeng Qu
This map shows the geographic impact of Rongfeng Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongfeng Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongfeng Qu more than expected).
Fields of papers citing papers by Rongfeng Qu
This network shows the impact of papers produced by Rongfeng Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongfeng Qu. The network helps show where Rongfeng Qu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rongfeng Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 17 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 4 | |
| 6 | 2021 | 14 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 11 | |
| 10 | 2019 | 42 | |
| 11 | 2017 | 35 | |
| 12 | MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting CXCL12. | 2017 | 22 |
| 13 | 2015 | 8 | |
| 14 | Upregulation of cyclooxygenase-2 is associated with activation of the alternative nuclear factor kappa B signaling pathway in colonic adenocarcinoma. | 2015 | 32 |
| 15 | 2014 | 69 |
About Rongfeng Qu
Rongfeng Qu is a scholar working on Cancer Research, Molecular Biology and Reproductive Medicine, having authored 15 papers that have together received 282 indexed citations. Recurring topics across this work include Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (8 papers), Lymphoma Diagnosis and Treatment (2 papers), Virus-based gene therapy research (1 paper), Conducting polymers and applications (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Cancer Research (129 citations), Reproductive Medicine (58 citations) and Molecular Biology (174 citations). Rongfeng Qu has collaborated with scholars based in China. Frequent co-authors include Yarong Li, Wenxian Zeng, Ying He, Xiue Tian, Guang Shi, Yaqing Zhang, Yi Zheng, Rui Liu, Cong Liang and Guizhen Zhang. Their work appears in journals such as Gene, Medicine and Reproduction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.